Rower Michelle Posted March 13, 2020 Share Posted March 13, 2020 https://clinicaltrials.gov/ct2/show/NCT03831932?id=NCT03831932&draw=2&rank=1 One of our group members just enrolled in this Phase I EGFR clinical trial which involves a novel approach called rational combination therapy which uses another drug to hopefully increase the efficacy of the TKI. Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.